Health Care Delivery Solutions (MHS GENESIS)_Industry Engagement Q_A_8 Feb_2024_Final.pdf

PDF 140 KB Posted

Attached to
Health Care Delivery Solutions (MHS GENESIS)
Solicitation number
HT0038-24-R-0004
Issued by

About this file

This document contains questions and answers from an industry engagement session regarding the Health Care Delivery Solutions opportunity. The Defense Health Agency is seeking input from industry to assist in developing the acquisition strategy for managing the Military Health System GENESIS electronic health record and associated clinical applications. The agency provided a risk analysis and is requesting feedback on areas including system integration, vendor management, and license administration. Questions from industry were answered in the document to help inform potential responses that are due by February 5, 2024. The session was held virtually on February 8, 2024 to discuss the opportunity.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Number Question Response

Where will the materials from the 2/8 session (PowerPoint presentation and Excel attachment) be shared?

The briefing and Work Breakdown Structure (WBS) Risk Analysis Excel sheet were posted on Sam.gov on Feb 5, 2024.

2 Are you open to hearing input on procurement strategy?

Yes. The Government is open to input on procurement strategy. If you choose to provide input, please include as part of the additional two (2) pages for additional industry feedback.

3 Do you want the feedback at lowest WBS level? Yes, please provide feedback at the lowest level of the WBS.

Is the government's goal for license management to maintain the current arrangement with its federal partners, or is the government interested in a future state where licenses are managed directly by its other partners?

The government is open to industry feedback on innovative recommendations and best practices for license management. Please provide feedback in response to the 'license management' questions.

5 How many versions of MHS GENESIS are deployed at any given time? There is only one version of MHS GENESIS in production.

6 Do legacy versions exist that needs to be updated? See response to question number 5.

7 What is the plan and timeline to achieve a common DHA-wide workflow for common functions? There are standardized and documented workflows of how users utilize the system (hands on keyboard).

8 How will DevMAC complement Health Care Delivery? This question is non-relevant. It does not seek clarification to the Government's request.

How confident is the government that it has comprehensive documentation to all software rights and code? This question is non-relevant. It does not seek clarification to the Government's request.

10 Can the government outline the model and approach they are transitioning from?

DHMSM has transitioned from a project -focused model to a product -focused model.

The original contract strategy was a single contractor to provide the entire solution. The original strategy is not a prerequisite to shape the feedback requested from industry.

11 In the WBS risk analysis spreadsheet, sections 2.12.1 / 2.12.2 are present in the 'Keep Operational' tab but not in the 'Modernizing' or 'Maximizing' tabs. Was that intentional?

Yes, the Government's assessment is that the cyber and testing components of System Independent Verification and Validation are separate activities to keep the system operational but may not apply to modernize or maximize the system. If industry identifies the need to break out into a lower level, please do so.

In the WBS risk analysis spreadsheet, multiple rationales state that 'documentation is not digestible.' What does that mean?

Documentation is not digestible' is meant to describe the complexity of the system and the feasibility of using the documentation to fully understand the technical configuration.

13 Are you open to ideas about changes to existing processes or measures? Yes. Feedback may be included as part of additional two (2) pages for additional industry feedback.

Health Care Delivery Solutions (MHS GENESIS) Industry Engagement Questions and Answers

Feb 08, 2024

Health Care Delivery Solutions (MHS GENESIS) Industry Engagement Questions and Answers

Feb 08, 2024

14 How can industry understand the risk of where DHA is at today? This question is non-relevant. It does not seek clarification to the Government's request.

When thinking through customization vs configuration, will the maintaining vendor(s) get access to the code?

This question is non-relevant. It does not seek clarification to the Government's request.

16 Do you have boundaries or approaches to customizations to workflows or solutions?

The government has taken the position to configure the Commercial-off-the-Shelf (COTS) solution to the maximum extent possible instead of customizing the solution.

17 When completing the submissions can we utilize both PowerPoint and Word?

Specific to the Additional Strategy Topics, industry may choose between PowerPoint and Word to reply to the specific topic. Each topic should not exceed the single topic page limit.

For example, if it is best to address topic #1 in word and topic #2 and #3 in PowerPoint, then submission would include for topic #1 a word document is limited to 1.5 pages for topic #1, the PowerPoint is limited to 4 slides for topic #2, and the PowerPoint is limited to 4 slides for topic #3. All documents may be converted to pdf prior to submission, but is not required.

18 Does the government have a hypothesis on the timeline for acquisition? This question is non-relevant. It does not seek clarification to the Government's request.

Does a new vendor get access to the source code, software frameworks, and development tool chains of this COTS product, if there any need for customization? If yes, what software tools have been used to developed the COTS product?

This question is non-relevant. It does not seek clarification to the Government's request.

As it relates to license management, does the MOU/SLA that's in place with the partners for which you manage licenses provide any kind of administrative or service fee for that management? Or is there a non-monetary exchange for that management?

The current license management arrangement is not a prerequisite to shape any future license management arrangements

Are the solution providers (Oracle, 3M, etc.) subcontracted by the integrator (Leidos) or directly contracted with the Government? Would a new integrator need to establish contracts with all the current products/ solution providers?

Refer to slide #22 System Integration/ Vendor Management for the current arrangement.

The Government is asking industry how best to do system integration and vendor management (refer to slide #25).

22 Can you confirm whether the Health Care Delivery Solutions opportunity following this RFI will be considered a "Prime Mission Product Support Contract"?

This question is non-relevant. It does not seek clarification to the Government's request.

23 Is submitting the industry feedback a pre-requisite to responding the final RFP? This question is non-relevant. It does not seek clarification to the Government's request.

24 When will the draft and final RFP be released? This question is non-relevant. It does not seek clarification to the Government's request.

25 Is this requirement going to be solicited as a multiple award contract or a single award contract? This question is non-relevant. It does not seek clarification to the Government's request.

Health Care Delivery Solutions (MHS GENESIS) Industry Engagement Questions and Answers

Feb 08, 2024

26 Will the follow-on contract be a full and open or small business set aside or a combination? This question is non-relevant. It does not seek clarification to the Government's request.

27 What is the timeframe for modernization of the current systems that are described in the slides? This question is non-relevant. It does not seek clarification to the Government's request.

With multiple solicitations coming out from PEO DHMS this year, are there any OCI concerns between the other DHMS solicitations and Healthcare Delivery Solutions that industry should be informed?

This question is non-relevant. It does not seek clarification to the Government's request.

When (after production or integrated into the development process) and how (test/evaluation) does DHMS envision evaluating customer experience (CX)? What are the standards for evaluating CX/KPIs for CX that DHMS envisions?

This question is non-relevant. It does not seek clarification to the Government's request.

During the 02/08 industry day, DHA personnel repeated the phrase "configuration not customization" multiple times. Can the government please provide their definitions of both "configuration" and "customization"? Please provide how the government distinguishes the differences in the terminology.

Generally, configuration involves leveraging a COTS product and arranging it to meet the Government’s requirement. Customization involves developing custom code and changing the commercial baseline of the COTS product to meet the Government’s requirement.

Industry Day Q&A

File details come from the government source that posted it. Updated .